External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home CTAD 2022
Roche and Genentech at

CTAD 2022

November 29 - December 02
San Francisco, USA
ctad-alzheimer
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:15 PM
Duration 60mins San Francisco, USA
Topline Results of Phase III GRADUATE I & II Pivotal Trials with Subcutaneous Gantenerumab
Bateman R, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Scott Turner R, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler-Klein M, Fox NC, Cummings JL, Fontoura P, Doody RS
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:45 PM
Duration 15mins San Francisco, USA
Plasma Biomarker Findings from the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia Trial
Reiman EM, Lopera F, Rios-Romenets S, Schiffman C, Hibar D, Hu N, Kollmorgen G, Giraldo M, Acosta N, Espinoa A, Villegas G, Munoz C, Serna L, Herrera K, Su Y, Alexander R, Quiroz YT, Doody RS, Langbaum JB, Tariot PN, Sink K, Bittner T
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.